Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Where this comes from

• Record sourced from PubMed, PMID 32584902.
• Also identified by DOI 10.1371/journal.pone.0235580 and PMC identifier 7316286.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.